Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helioblock SX Cream safety in pediatric subjects
NCT00326274Phase 3Completed
- Sponsor
- L'Oréal
- Start
- May 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Helioblock SX in sunburn, sponsored by L'Oréal. Primary endpoint: Long term safety at 6 months. Started May 2006; status: completed.
02
Drugs
Helioblock SX
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT00326274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326274.